These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9645504)

  • 1. The lipolysis stimulated receptor: a gene at last.
    Bihain BE; Yen FT
    Curr Opin Lipidol; 1998 Jun; 9(3):221-4. PubMed ID: 9645504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning of a lipolysis-stimulated remnant receptor expressed in the liver.
    Yen FT; Masson M; Clossais-Besnard N; André P; Grosset JM; Bougueleret L; Dumas JB; Guerassimenko O; Bihain BE
    J Biol Chem; 1999 May; 274(19):13390-8. PubMed ID: 10224102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of activation and functional significance of the lipolysis-stimulated receptor. Evidence for a role as chylomicron remnant receptor.
    Mann CJ; Khallou J; Chevreuil O; Troussard AA; Guermani LM; Launay K; Delplanque B; Yen FT; Bihain BE
    Biochemistry; 1995 Aug; 34(33):10421-31. PubMed ID: 7654696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E structure and substrate and receptor-binding activities of triglyceride-rich human plasma lipoproteins in normo- and hypertriglyceridemia.
    Dergunov AD
    Biochemistry (Mosc); 2004 Jul; 69(7):720-37. PubMed ID: 15310270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of the lipolysis stimulated receptor in adult and embryonic murine tissues and lethality of LSR-/- embryos at 12.5 to 14.5 days of gestation.
    Mesli S; Javorschi S; Bérard AM; Landry M; Priddle H; Kivlichan D; Smith AJ; Yen FT; Bihain BE; Darmon M
    Eur J Biochem; 2004 Aug; 271(15):3103-14. PubMed ID: 15265030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a lipolysis-stimulated receptor that is distinct from the LDL receptor and the LDL receptor-related protein.
    Yen FT; Mann CJ; Guermani LM; Hannouche NF; Hubert N; Hornick CA; Bordeau VN; Agnani G; Bihain BE
    Biochemistry; 1994 Feb; 33(5):1172-80. PubMed ID: 7509190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
    Alaupovic P; Wang CS; McConathy WJ; Weiser D; Downs D
    Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low density lipoprotein uptake: holoparticle and cholesteryl ester selective uptake.
    Rhainds D; Brissette L
    Int J Biochem Cell Biol; 1999 Sep; 31(9):915-31. PubMed ID: 10533283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice.
    Frick F; Bohlooly-Y M; Lindén D; Olsson B; Törnell J; Edén S; Oscarsson J
    Am J Physiol Endocrinol Metab; 2001 Dec; 281(6):E1230-9. PubMed ID: 11701438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
    Marais AD
    Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors for triglyceride-rich lipoproteins and their role in lipoprotein metabolism.
    Beisiegel U
    Curr Opin Lipidol; 1995 Jun; 6(3):117-22. PubMed ID: 7647999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The very low density lipoprotein (VLDL) receptor--a peripheral lipoprotein receptor for remnant lipoproteins into fatty acid active tissues.
    Takahashi S; Sakai J; Fujino T; Miyamori I; Yamamoto TT
    Mol Cell Biochem; 2003 Jun; 248(1-2):121-7. PubMed ID: 12870663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.
    Linton MF; Hasty AH; Babaev VR; Fazio S
    J Clin Invest; 1998 Apr; 101(8):1726-36. PubMed ID: 9541504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):14-28. PubMed ID: 10685027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis.
    Huang Y; Ji ZS; Brecht WJ; Rall SC; Taylor JM; Mahley RW
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2952-9. PubMed ID: 10591675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism.
    Shachter NS
    Curr Opin Lipidol; 2001 Jun; 12(3):297-304. PubMed ID: 11353333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members.
    MacArthur JM; Bishop JR; Stanford KI; Wang L; Bensadoun A; Witztum JL; Esko JD
    J Clin Invest; 2007 Jan; 117(1):153-64. PubMed ID: 17200715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.
    Fan J; Ji ZS; Huang Y; de Silva H; Sanan D; Mahley RW; Innerarity TL; Taylor JM
    J Clin Invest; 1998 May; 101(10):2151-64. PubMed ID: 9593771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.